Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

71.22 +6.14 (+9.44%)
Streaming Delayed Price Updated: 12:47 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
46 47 Next >
News headline image
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now ↗
The stock isn't normally this cheap, and investors should take advantage. 
Via The Motley Fool
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
From DexCom, Inc.
Via Business Wire
News headline image
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Is DexCom a Millionaire-Maker Stock? ↗
The stock has delivered superior returns in the past 19 years. 
Via The Motley Fool
News headline image
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $38,000 Today ↗
 
Via Benzinga
News headline image
Kirby McInerney LLP Reminds Dexcom Inc. (DXCM) Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation. ↗
DEXCOM INC (NASDAQ:DXCM): a strong growth stock preparing for the next leg up?. 
Via Chartmill
News headline image
Jim Cramer Doesn't Like Carnival Right Now: Royal Caribbean Is 'The One You Want' ↗
Royal Caribbean has "the best systems right now," Jim Cramer says. "It's got the best numbers. It's the one you want, not Carnival." 
Via Benzinga
News headline image
DXCM Lawsuit Reminder: Robbins LLP Encourages DexCom Inc. Stockholders to Seek Counsel for Class Action Lawsuit
From Robbins LLP
Via GlobeNewswire
News headline image
ROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device ↗
The companies are now duking it out for a new population of CGM users. 
Via Investor's Business Daily
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
From DexCom, Inc.
Via Business Wire
News headline image
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Shareholder Rights Law Firm Robbins LLP Urges DXCM Stockholders with Large Losses to Contact the Firm for Information About the DexCom Inc. Lawsuit
From Robbins LLP
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Dexcom Inc. (DXCM) Investors
From Kirby McInerney LLP
Via Business Wire
News headline image
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
ROSEN, A TOP RANKED LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spire Global, DexCom, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DXCM Class Action Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the DexCom Inc. Class Action
From Robbins LLP
Via GlobeNewswire
News headline image
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients ↗
DexCom's Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor, is now available without a prescription. Designed for people with Type 2 diabetes and prediabetes, Stelo... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.